Loading company…
Momenta Pharmaceuticals develops therapeutics for rare immune-mediated diseases in neurology and hematology.
Founded in 2001 and based in Massachusetts, US, Momenta Pharmaceuticals, formerly Mimeon Inc., focuses on characterizing and engineering neurology and hematology therapeutics for patients with rare immune-mediated diseases.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in